Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
…, SJ Chapman, A Clayton, M Cullen, O Dempsey… - Science, 2016 - science.org
Lung infections with Mycobacterium abscessus, a species of multidrug-resistant nontuberculous
mycobacteria, are emerging as an important global threat to individuals with cystic …
mycobacteria, are emerging as an important global threat to individuals with cystic …
[HTML][HTML] Reasons for and consequences of missed appointments in general practice in the UK: questionnaire survey and prospective review of medical records
…, VL Allgar, DA Lawlor, O Dempsey - BMC family …, 2005 - Springer
Background Missed appointments are a common occurrence in primary care in the UK, yet
little is known about the reasons for them, or the consequences of missing an appointment. …
little is known about the reasons for them, or the consequences of missing an appointment. …
[HTML][HTML] The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
…, SJ Bourke, SC Charman, J Collinson, O Dempsey… - Journal of cystic …, 2020 - Elsevier
With the growing SARS-CoV-2 pandemic, we need to better understand its impact in specific
patient groups like those with Cystic Fibrosis (CF). We report on 181 people with CF (32 …
patient groups like those with Cystic Fibrosis (CF). We report on 181 people with CF (32 …
Missed appointments in primary care: questionnaire and focus group study of health professionals.
M Husain-Gambles, RD Neal, O Dempsey… - British Journal of …, 2004 - bjgp.org
BACKGROUND: The issue of missed appointments in primary care is important for patients
and staff. Little is known about how missed appointments, and the people who miss them, …
and staff. Little is known about how missed appointments, and the people who miss them, …
Causes of pulmonary granulomas: a retrospective study of 500 cases from seven countries
Background The frequencies of various causes of pulmonary granulomas in pathological
material are unknown, as is the influence of geographical location on aetiology. The aim of this …
material are unknown, as is the influence of geographical location on aetiology. The aim of this …
Rheumatoid arthritis related interstitial lung disease–improving outcomes over 25 years: a large multicentre UK study
…, A Price-Forbes, D Middleton, O Dempsey… - …, 2021 - academic.oup.com
Objective This study explores whether the prognosis of interstitial lung disease in rheumatoid
arthritis (RA-ILD) has improved over time and assesses the potential influence of drug …
arthritis (RA-ILD) has improved over time and assesses the potential influence of drug …
Screening for Bronchial Hyperresponsiveness Using Methacholine and Adenosine Monophosphate: Relationship to Asthma Severity and β2-Receptor Genotype
SJ Fowler, OJ Dempsey, EJ Sims… - American journal of …, 2000 - atsjournals.org
Bronchial hyperresponsiveness (BHR) is a key feature of asthma and may be measured by
direct methacholine challenge or indirect adenosine monophosphate (AMP) challenge. We …
direct methacholine challenge or indirect adenosine monophosphate (AMP) challenge. We …
[HTML][HTML] Clinical review: idiopathic pulmonary fibrosis—past, present and future
OJ Dempsey - Respiratory medicine, 2006 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is an important, and devastating, interstitial lung disease.
It has a median mortality of only 3 years, worse than many cancers, and its incidence …
It has a median mortality of only 3 years, worse than many cancers, and its incidence …
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
…, SC Charman, J Collinson, O Dempsey… - Journal of Cystic …, 2022 - Elsevier
Background This international study aimed to characterise the impact of acute SARS-CoV-2
infection in people with cystic fibrosis and investigate factors associated with severe …
infection in people with cystic fibrosis and investigate factors associated with severe …
Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids
AM Wilson, OJ Dempsey, EJ Sims, BJ Lipworth - Chest, 2001 - Elsevier
Objective To assess the addition of a leukotriene receptor antagonist and a long-acting ββ 2
-agonist as second-line therapy in asthma. Design Placebo-controlled, double-dummy, …
-agonist as second-line therapy in asthma. Design Placebo-controlled, double-dummy, …